Patient-delivered partner therapy for sexually transmitted diseases as practiced by U.S. physicians

Sexually Transmitted Diseases

Volumn 32, Issue 2, 2005, Pages 101-105

  Hogben, Matthew ^a,d   McCree, Donna H ^a   Golden, Matthew R ^b,c  

^a CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^b UNIVERSITY OF WASHINGTON   (United States)

^c Public Health Seattle King County   (United States)

^d CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; ARTICLE; CHLAMYDIASIS; CLINICAL PRACTICE; CONTROLLED STUDY; DEMOGRAPHY; EMERGENCY WARD; EXPERIMENTAL THERAPY; FEMALE; GENERAL PRACTICE; GONORRHEA; HOSPITAL DEPARTMENT; HUMAN; INFECTION PREVENTION; INTERNAL MEDICINE; MALE; MEDICAL SPECIALIST; NORMAL HUMAN; PATIENT DELIVERED PARTNER THERAPY; PATIENT INFORMATION; PRACTICE GUIDELINE; SEXUALITY; TREATMENT OUTCOME; UNITED STATES;

ADOLESCENT; ADULT; ANTI-INFECTIVE AGENTS; CHLAMYDIA INFECTIONS; CHLAMYDIA TRACHOMATIS; DRUG UTILIZATION; FEMALE; GONORRHEA; HUMANS; MALE; MIDDLE AGED; PATIENT COMPLIANCE; PHYSICIAN'S PRACTICE PATTERNS; SEXUAL PARTNERS; SEXUALLY TRANSMITTED DISEASES; UNITED STATES;

EID: 12744259981     PISSN: 01485717     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.olq.0000151417.43230.18     Document Type: Article

References (14)

1. Parran T. Shadow on the Land. New York: Reynal & Hitchcock, 1937.
2. Rothenberg RB, McElroy PD, Wilce MA, Muth SQ. Contact tracing: Comparing the approaches for sexually transmitted diseases and tuberculosis. Int J Tuberc Lung Dis 2004; 7:S342-S348.
3. Oxman AD, Scott EAF, Sellers JW, et al. Partner notification for sexually transmitted diseases: An overview of the evidence. Can J Public Health 1994; 85(suppl 1):S41-S47.
4. Macke B, Maher J. Partner notification in the United States: An evidence-based review. Am J Prev Med 1999; 17:230-242.
5. Golden MR, Hogben M, Handsfield HH, et al. Partner notification for HIV and STD in the United States: Low coverage for gonorrhea, chlamydial infection and HIV. Sex Transm Dis 2003; 30:490-496.
6. Klausner JD, Chaw JK. Patient-delivered therapy for chlamydia: Putting research into practice. Sex Transm Dis 2003; 30:509-511.
7. Golden MR, Whittington WLH, Handsfield HH, et al. Partner management for gonococcal and chlamydial infection: Expansion of public health services to a private sector and expedited sex partner treatment through a partnership with commercial pharmacies. Sex Transm Dis 2001; 28:658-665.
8. Kissinger P, Brown R, Reed K, et al. Effectiveness of patient delivered partner medication for preventing recurrent Chlamydia trachomatis. Sex Transm Infect 1998; 74:331-333.
9. Ramstedt K, Forssman L, Johannisson G. Contact tracing in the control of Chlamydia trachomatis infection. Int J STD AIDS 1991; 2:116-118.
10. Schillinger JA, Kissinger P, Calvet H, et al. Patient-delivered partner treatment with azithromycin to prevent repeated chlamydia trachomatis infection among women: A randomized, control trial. Sex Transm Dis 2003; 30:49-56.
11. Golden MR, Whittington WLH, Handsfield HH, et al. Impact of expedited sex partner treatment on recurrent or persistent gonorrhea or chlamydial infection: A randomized controlled trial. New Engl J Med. In press.
12. McCree DH, Liddon NC, Hogben M, St. Lawrence JS. National survey of doctors' actions following the diagnosis of a bacterial STD. Sex Transm Infect 2003; 79:254-256.
13. St. Lawrence JS, Montano DE, Kasprzyk D, et al. STD screening, testing, case reporting, and clinical and partner notification practices: A national survey of US physicians. Am J Public Health 2002; 92:1784-1788.
14. Sexually transmitted disease surveillance, 2002. Atlanta: Centers for Disease Control and Prevention, 2003.